ClinicalTrials.gg
CompletedNCT07817836IDEAUpdated Sep 14, 2026

Urban Exposome and Biological Age

An observational study in Healthy Adult Participants, sponsored by University of Pavia. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-14.

Sponsored by University of Pavia · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
151
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to evaluate the impact of the urban exposome, including air pollution and lifestyle-related stressors, on biological aging, inflammatory pathways, oxidative stress, and DNA methylation patterns in healthy workers exposed to urban air pollution in the city of Pavia, Italy.

The study population included 151 adult workers, divided into two groups: outdoor workers (including police officers, taxi drivers, and dustmen) and an indoor control group composed of office workers from the University of Pavia and ICS Maugeri hospital with minimal outdoor exposure.

The main questions it aims to answer are:

  • Does chronic exposure to urban air pollutants such as NO2, SO2, O3, benzene, volatile organic compounds, and PM2.5 influence inflammatory cytokines, oxidative stress markers, and biological aging?
  • Is exposure to urban pollution associated with changes in DNA methylation patterns and epigenetic age acceleration?
  • How do lifestyle factors, nutritional status, sleep quality, physical activity, smoking habits, and perceived quality of life interact with the urban exposome and biological outcomes?

Researchers will compare outdoor workers with indoor workers to evaluate differences in environmental exposure, inflammatory biomarkers, oxidative stress, DNA methylation profiles, and estimated biological age.

Participants will:

  • Undergo clinical assessments, with interviews regarding occupational history.
  • Undergo anthropometric and nutritional evaluations, including body composition analysis and blood chemistry tests; answer questionnaires about physical activity, smoking habits, sleep quality, and perceived quality of life; undergo interviews about dietary habits.
  • Wear passive personal air samplers for approximately 5 working days to measure exposure to urban air pollutants.
  • Provide blood samples for analysis of inflammatory cytokines, oxidative stress markers, thyroid-related biomarkers, and epigenetic modifications.
  • Undergo DNA methylation analyses using epigenetic techniques to estimate biological age and evaluate associations between pollutant exposure and epigenetic changes.
  • Receive feedback regarding their environmental exposure and general health and nutritional status.

This interdisciplinary observational study adopts an exposome-based approach integrating environmental monitoring, occupational medicine, nutrition, and epigenetics to better understand the relationship between urban environmental exposure and human health.

02

Conditions studied

  • Healthy Adult Participants

Keywords

  • Exposome
  • Life Style
  • Nutritional Status
  • Aging
  • Oxidative Stress
  • Cytokines
  • Tobacco Smoking
  • Sleep Quality
  • Quality of Life
  • Air Pollution
  • Epigenomics
03

In context

Tobacco Smoking

264 studies on the registry are indexed under Tobacco Smoking; 42 are open to participants now.

This study's enrollment of 151 is below the median of 492 across 30 observational studies indexed under Tobacco Smoking.

Browse Tobacco Smoking studies →

Lead sponsor

University of Pavia is the lead sponsor of 144 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population consists of adult workers recruited in the city of Pavia, Italy, through ICS Maugeri IRCCS and collaborating occupational settings. 151 participants are enrolled, including workers predominantly employed outdoors in urban environments with regular exposure to traffic-related air pollution, such as municipal police officers, taxi drivers, and dustmen. A comparison group will include indoor office workers with minimal occupational exposure to outdoor urban pollution, recruited through occupational health surveillance programs at ICS Maugeri and affiliated institutions, including administrative personnel from the University of Pavia. The study focuses on evaluating the relationship between urban environmental exposure, lifestyle factors, biological aging, inflammation, oxidative stress, and epigenetic modifications.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older;
  • Male or female participants;
  • Ability and willingness to provide written ;
  • Employment in occupations performed predominantly outdoors in an urban environment with exposure to atmospheric pollution, i.e. employment as urban police officers, police personnel, public transport workers, taxi drivers, newsstand workers, or other outdoor urban workers in the city of Pavia;
  • Employment in predominantly indoor office-based occupations with minimal occupational exposure to outdoor urban air pollution (control group), i.e. workers undergoing occupational health surveillance at ICS Maugeri or affiliated institutions.

Exclusion criteria

Exclusion Criteria:

  • Current diagnosis of active oncological disease;
  • Current treatment with therapy;
  • Inability or unwillingness to provide ;
  • Medical conditions preventing participation in blood sampling or study assessments;
  • Pregnancy or breastfeeding (if applicable and according to Ethics Committee recommendations).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
151 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Outdoor exposed workers

    The group consists of outdoor workers, specifically traffic police, taxi drivers and dustmen working in Pavia city area (Italy). The group is highly exposed to urban air pollutants, therefore these urban workers are particularly vulnerable to biological effects such as genetic and hormonal alterations, oxidative stress, and inflammation, which could predispone to chronic non-communicable diseases. The exposome variables are compared between the Outdoor exposed workers group and the Indoor non-exposed workers group, to identify differences among the group considering biological clock, inflammatory status and oxidative stress as the main outcome.

  • Indoor non exposed workers

    The group consists of indoor workers, specifically administrative staff of Maugeri Clinic and office workers from the University of Pavia. They are minimally exposed to urban pollutants, therefore represent the "control" group of the study.

06

What researchers measure

Primary outcomes

  1. DNA Methylation Profile Associated With Urban Air Pollution Exposure

    DNA methylation patterns are evaluated in peripheral blood samples from participants exposed to different levels of urban air pollution. Genomic DNA is extracted and analyzed using bisulfite sequencing, quantitative polymerase chain reaction (qPCR), and pyrosequencing techniques to quantify DNA methylation in specific genomic regions. Methylation measures are evaluated in relation to participants' measured exposure to urban air pollutants.

    Time frame: Baseline

Secondary outcomes

  1. Biological Age Estimated using an Epigenetic Clock Analysis in Workers Exposed to Urban Air Pollution

    Biological age is estimated using an epigenetic clock algorithm based on DNA methylation patterns measured in peripheral blood samples. Biological age estimates are compared between workers highly exposed to urban air pollution during outdoor occupational activities and workers with minimal occupational exposure to outdoor urban air pollution.

    Time frame: Baseline

Other outcomes

  1. Blood Glucose Concentration

    Blood glucose concentration measured from the peripheral blood sample to characterize glucose metabolism. Unit: mg/dL

    Time frame: Baseline

  2. Serum Insulin Concentration

    Serum insulin concentration measured to characterize glucose and insulin metabolism. Unit: mIU/L

    Time frame: Baseline

  3. Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)

    HOMA-IR is calculated from fasting glucose and insulin concentrations as an estimate of insulin resistance.

    Time frame: Baseline

  4. Mean Corpuscular Volume

    Mean corpuscular volume (MCV) measured as part of the complete blood count. Unit: fL

    Time frame: Baseline

  5. Hemoglobin Concentration

    Hemoglobin concentration measured in peripheral blood as part of the complete blood count. Unit: g/L

    Time frame: Baseline

  6. Leukocyte Count

    Leukocyte count measured in peripheral blood as part of the complete blood count. Unit: 10\^9/L

    Time frame: Baseline

  7. Leukocyte Telomere Length in Relation to Urban Air Pollution Exposure

    Telomere length is measured in peripheral blood leukocytes as a biomarker of biological aging and cellular senescence. Analyses evaluate associations between telomere length and exposure to urban air pollutants.

    Time frame: Baseline

  8. Creatinine Concentration

    Serum Creatinine Concentration. Unit: mg/dL

    Time frame: Baseline

  9. Estimated Glomerular Filtration Rate

    Estimated glomerular filtration rate (eGFR) used to characterize renal function. Unit: mL/min/1.73 m²

    Time frame: Baseline

  10. Serum Folate Concentration

    Unit: µg/L

    Time frame: Baseline

  11. Serum Vitamin B12 Concentration

    Unit: ng/L

    Time frame: Baseline

  12. Plasma Homocysteine Concentration

    Unit: µmol/L

    Time frame: Baseline

  13. FIB-4 Index

    FIB-4 is a non-invasive index of liver fibrosis calculated from age, AST, ALT, and platelet count.

    Time frame: Baseline

  14. Aspartate Aminotransferase (AST) Concentration

    Unit: U/L

    Time frame: Baseline

  15. Alanine Aminotransferase (ALT) Concentration

    Unit: U/L

    Time frame: Baseline

  16. Gamma-Glutamyl Transferase Concentration

    Unit: U/L

    Time frame: Baseline

  17. Total Cholesterol Concentration

    Unit: mg/dL

    Time frame: Baseline

  18. HDL Cholesterol Concentration

    Unit: mg/dL

    Time frame: Baseline

  19. LDL Cholesterol Concentration

    Unit: mg/dL

    Time frame: Baseline

  20. Triglyceride Concentration

    Unit: mg/dL

    Time frame: Baseline

  21. Serum 25-Hydroxyvitamin D Concentration

    Unit: µg/L

    Time frame: Baseline

  22. Serum Thyroid-Stimulating Hormone (TSH) Concentration

    Unit: mUI/L

    Time frame: Baseline

  23. Serum Free Triiodothyronine (FT3) Concentration

    Unit: ng/L

    Time frame: Baseline

  24. Serum Free Thyroxine (FT4) Concentration

    Unit: ng/dL

    Time frame: Baseline

  25. Anti-Thyroglobulin Antibody Concentration

    Unit: KUI/L

    Time frame: Baseline

  26. Anti-Thyroid Peroxidase Antibody Concentration

    Unit: KUI/L

    Time frame: Baseline

  27. Body Mass Index (BMI)

    Body mass index (BMI) is calculated as body weight in kilograms divided by height in meters squared (kg/m²) and is used to assess overall body size.

    Time frame: Baseline

  28. Waist-to-Hip Ratio (WHR)

    Waist-to-hip ratio (WHR) is calculated from waist and hip circumference measurements as an indicator of body fat distribution.

    Time frame: Baseline

  29. Waist-to-height ratio (WHtR)

    Waist-to-height ratio (WHtR) is calculated from waist circumference and height measurements as an indicator of central adiposity.

    Time frame: Baseline

  30. Bioelectrical Impedance Phase Angle

    Phase angle is measured by bioelectrical impedance analysis using the BIA 101 device (BIVA® PRO, Akern) as an indicator of cellular integrity and body composition status. Phase angle is reported in degrees.

    Time frame: Baseline

  31. Handgrip Strength

    Handgrip strength is measured using a digital handgrip dynamometer (GripwiseTech). 3 test on non dominant hand are repeated and the mean value is used as an indicator of handgrip strenght.

    Time frame: Baseline

  32. Liver Stiffness Measured by Transient Elastography

    Liver stiffness is measured by transient elastography (FibroScan® Compact 530, Echosens SA) and reported in kilopascals (kPa).

    Time frame: Baseline

  33. Controlled Attenuation Parameter (CAP)

    The Controlled Attenuation Parameter (CAP) is measured by transient elastography (FibroScan® Compact 530, Echosens SA) to estimate hepatic steatosis.

    Time frame: Baaseline

  34. Mediterranean Diet Adherence score (Medi-Lite)

    Adherence to the Mediterranean diet is assessed using the validated MEDI-LITE questionnaire (doi: 10.1080/09637486.2017.1287884.). The questionnaire evaluates the usual consumption of nine dietary components: fruit, vegetables, legumes, cereals, fish and fish products, meat and processed meat, milk and dairy products, alcoholic beverages, and olive oil. Each component is assigned a score ranging from 0 to 2. For food groups characteristic of the Mediterranean dietary pattern (i.e. fruit, vegetables, legumes, cereals, and fish), higher consumption is assigned a higher score, whereas lower consumption of meat and processed meat and milk and dairy products received a higher score. Olive-oil use is scored according to its reported frequency of consumption. The original MEDI-LITE score ranges from 0 to 18, with higher values indicating greater adherence to the Mediterranean dietary pattern.

    Time frame: Baseline

  35. Dietary Inflammatory Index (DII)

    The Dietary Inflammatory Index (DII) is calculated from dietary intake data obtained through a 24-hour dietary recall collected through the Handydiet® software to estimate the inflammatory potential of participants' diets.

    Time frame: Baseline

  36. Physical Activity Level (IPAQ-SF)

    Physical activity is assessed using the validated International Physical Activity Questionnaire Short Form (IPAQ-SF). The seven-item questionnaire investigates the frequency and duration of walking and moderate- and vigorous-intensity physical activity performed during the previous seven days, together with time spent sitting. Weekly physical activity was expressed as metabolic equivalent of task minutes per week (MET-min/week), calculated by multiplying the MET coefficient assigned to each activity intensity by the reported duration and weekly frequency of the activity. Participants were classified as having low, moderate, or high physical activity levels according to the IPAQ scoring protocol (doi: 10.1249/01.MSS.0000078924.61453.FB.).

    Time frame: Baseline

  37. Sleep Quality (PSQI)

    Sleep quality during the previous month is assessed using the Pittsburgh Sleep Quality Index (PSQI) (doi: 10.1016/0165-1781(89)90047-4. PMID: 2748771.). The PSQI comprises 19 self-rated items grouped into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component is scored from 0 to 3, and the seven component scores are summed to generate a global score ranging from 0 to 21. Higher scores, and in particular a cut-off of 5, indicate poorer subjective sleep quality.

    Time frame: Baseline

  38. Quality of Life (WHOQOL-BREF)

    Quality of life is assessed using the abbreviated version of the World Health Organization Quality of Life questionnaire (doi: 10.1017/s0033291798006667.). The WHOQOL-BREF comprises 26 items, including two general questions on overall quality of life and perceived health and 24 items covering four domains: physical health, psychological health, social relationships, and environment. Items are rated using five-point response scales. Domain scores are calculated according to the instrument scoring guidelines and transformed to a 4-20 or 0-100 scale, with higher scores indicating better perceived quality of life.

    Time frame: Baseline

  39. Alcohol consumption pattern

    Alcohol consumption is assessed through a structured interview investigating drinking frequency and the usual number of Alcohol Units consumed per each drinking occasion. Participants are classified as reporting no current alcohol consumption, alcohol consumption without a binge pattern, or binge-pattern alcohol consumption. Binge-pattern drinking is defined as the consumption of at least four Alcohol Units for women or at least five Alcohol Units for men on a single drinking occasion. One alcohol Unit equals to 12g of ethanol and is approximately equivalent to the quantity of alcohol in a bottle (330 ml) of beer, in a glass (125 ml) of wine, in a shot (40 ml) of spirit.

    Time frame: Baseline

  40. Smoking status

    Smoking habits are assessed through a structured interview. Participants are classified as current, former, or never smokers. Additional information collected includes the average number of cigarettes smoked per day and the duration of smoking for current and former smokers.

    Time frame: Baseline

  41. Personal exposure to Ozone (O₃) in warm season

    Personal exposure to ozone (O₃) is assessed in warm season using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  42. Personal Exposure to Nitrogen Dioxide (NO₂)

    Personal exposure to nitrogen dioxide (NO₂) is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  43. Personal Exposure to Sulfur Dioxide (SO₂)

    Personal exposure to sulfur dioxide (SO₂) is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  44. Personal Exposure to Benzene (C₆H₆)

    Personal exposure to Benzene (C₆H₆) is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  45. Personal exposure to Toluene

    Personal exposure to toluene is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  46. Personal exposure to Ethylbenzene

    Personal exposure to ethylbenzene is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  47. Personal exposure to Xylenes

    Personal exposure to xylenes is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  48. Personal exposure to Naphthalene

    Personal exposure to naphthalene is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  49. Personal exposure to C9 Aromatic Hydrocarbons

    Personal exposure to C9 aromatic hydrocarbons is assessed using passive diffusion samplers worn by participants during their usual daily activities over a five consecutive day monitoring period. Unit of measure: µg/m3

    Time frame: Baseline

  50. Serum Chemokine CCL2 Concentration

    Serum CCL2 concentration is measured to assess systemic inflammatory responses associated with urban air pollution exposure. CCL2 concentrations are analyzed in relation to participants' measured exposure to urban air pollutants. Unit of measure: pg/mL

    Time frame: Baseline

  51. Serum Chemokine CXCL8 Concentration

    Serum CXCL8 concentration is measured to assess systemic inflammatory responses associated with urban air pollution exposure. CXCL8 concentrations are analyzed in relation to participants' measured exposure to urban air pollutants. Unit of measure: pg/mL

    Time frame: Baseline

  52. Serum Chemokine CXCL10 Concentration

    Serum CXCL10 concentration is measured to assess systemic inflammatory responses associated with urban air pollution exposure. CXCL10 concentrations are analyzed in relation to participants' measured exposure to urban air pollutants. Unit of measure: pg/mL

    Time frame: Baseline

07

Study locations

1 site
  • Occupational medicine Unit
    Pavia, PV 27100, Italy
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2024 to primary completion in Oct 2025, 11 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2026
First posted
Sep 14, 2026
StartActual
Nov 21, 2024
Primary completionActual
Oct 30, 2025
CompletionActual
Nov 17, 2025
Last update
Sep 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07817836
Responsible party
Sponsor
First posted
Sep 14, 2026
Start date
Nov 21, 2024
Primary completion
Oct 30, 2025
Completion
Nov 17, 2025
Last update
Sep 14, 2026

Study contacts

Stefano M Candura, MD, Prof.
principal investigator · Occupational medicine Unit, ICS Maugeri IRCCS, Pavia, Italy.

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion